glp-1 coverage news today insurers Department of Insurance Issues First-Ever Report Insurance coverage just changed for

Patients who struggle with appetite control, cravings, and overeating are often good candidates for GLP-1, particularly if theyve already tried a traditional diet and exercise without success

Learning Assessment Time: 33 Minutes Rehabilitation professionals are increasingly likely to manage patients on GLP-1 medications like Ozempic, Wegovy, and Mounjaro, which are revolutionary in their efficacy in promoting weight loss in patients with obesity and improving glycemic control in patients with type 2 diabetes

Effects of once-weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trials

Those who recevied the placebo (no active drug) on average experienced 14% weight regain whilst those who continued on Tirzepatide had a further average weight loss of 5.5%

Tirzepatide is technically a dual agonist GLP-1/GIP (glucose-dependent insulinotropic polypeptide) Liraglutide (Saxenda and Victoza) Each of these works in a similar way, but differs in terms of how long they stay active in the body and how they interact with different receptors

Heres what to expect: The typical timeline: For most women, periods get back on a regular schedule within 1-3 months after stopping GLP-1 medications